Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomyFrançois Vercruysse, Marie‐Elise Truchetet, François Lifermann et al.|Arthritis Research & Therapy|2019Cited by 75
Safety and Efficacy Of Rituximab In adult’s Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospective French ITP-Ritux RegistryMehdi Khellaf, Bertrand Godeau, Olivier Fain et al.|Blood|2013Cited by 4